The market gave the whole eVTOL group a rough session, but the bigger story was not just price weakness. It was a growing gap between headline progress and the physical assets needed to back that progress up. Joby kept building the case for early U.S. operations in 2026, Archer got a real policy win through the White House eIPP structure, and EHang got hit even harder than the U.S. names despite having no fresh company-specific negative catalyst in the daily file.
What matters now is not whether the sector can generate good headlines. It is whether each company has enough aircraft, enough capital, and enough institutional support to turn those headlines into repeatable commercial proof. Let’s break this down.
Q1: Joby는 2026년 조기 운영을 예고하면서도 생산 목표는 2027년 월 4대다. 만약 2026년 eIPP 실운영과 TIA용 FAA-conforming 시험을 동시에 돌려야 한다면, 현재 공개된 1대의 FAA-conforming 기체와 2027년 기준 월 4대 생산체제 사이의 간극은 얼마나 큰가? 2026년 일정은 실제 기체 수 부족으로 먼저 막히는 것 아닌가?
Yes, that gap looks real, and I think aircraft availability is one of the clearest underappreciated bottlenecks in Joby’s 2026 story.
Here’s the thing: the public disclosures in today’s input files show impressive momentum, but they do not show fleet depth. Joby said its first FAA-conforming aircraft took flight on March 11, and the article summary is very specific that this aircraft is the first of the production aircraft intended to support Type Inspection Authorization, or TIA, testing. The same summary also says Joby plans to begin U.S. operations in 2026 under the White House-backed eIPP framework, which spans 10 states and is supposed to generate real operational data with FAA, DOT, and local authorities involved. Then there is the production disclosure: Joby’s own materials point to a 2027 target of producing four aircraft per month.
Those three facts do not sit together comfortably. One FAA-conforming aircraft is enough to prove progress. It is not enough to remove scheduling conflict.
Why? Because a single conforming aircraft cannot do everything at once. If it is being used for FAA-credit testing in support of TIA preparation, its schedule is already valuable and constrained. If the company also wants to run demonstration flights, operational rehearsals, route proving, pilot training, partner showcases, and potentially early eIPP-linked service activity in 2026, every one of those uses competes for limited aircraft time, maintenance windows, crews, and engineering support.
The March 13 Joby IR summary makes this tension more obvious, not less. It mentions the piloted San Francisco Bay flight, the start of the 2026 Electric Skies Tour, eIPP-linked early operating opportunities, and the 2027 goal of four aircraft per month. That reads like a company trying to advance certification, public visibility, and commercial readiness at the same time. Strategically, that makes sense. Operationally, it suggests the fleet may be thinner than the narrative implies.
A conservative read from the disclosed data is that Joby likely needs more than one aircraft just to avoid internal trade-offs. At minimum, there is a logic for separating certification-focused FAA-conforming work from public demonstrations and early operational activity. The problem is that the public file set only confirms one FAA-conforming aircraft in flight so far. It does not confirm a broader available fleet count for 2026 operations.
That is why the 2027 production target matters so much. Four aircraft per month sounds strong, but it is explicitly a 2027 manufacturing goal, not a 2026 delivered-fleet fact. Investors should not pull that target backward and assume it solves the 2026 asset constraint. If anything, the need to highlight a 2027 production ramp tells you the company is still in transition from milestone aircraft to repeatable fleet output.
So is the 2026 timeline fake? No. But it does look narrower than the headline suggests. Joby may still be able to start some form of 2026 operations under eIPP. The question is what “operations” really means. If it means tightly managed, limited-scope flights designed to generate data and validate routes, then one disclosed conforming aircraft plus other non-disclosed or non-conforming assets might be enough to preserve the milestone. If investors are imagining a broader, more flexible operational launch running in parallel with serious TIA progress, the current disclosed fleet evidence does not support that confidence.
My directional take is bearish on expectations, not on the company. Joby’s certification story still looks strong. But the 2026 commercialization narrative may hit a hardware bottleneck before it hits a regulatory one. Until the company shows more than a single FAA-conforming aircraft and gives clearer visibility into what aircraft are allocated to TIA, demo work, and early operations, the real risk is that 2026 becomes a symbolic start rather than an operationally deep one.
Q2: Archer는 White House eIPP로 플로리다·뉴욕·텍사스 3개 주 운영 테스트 기회를 확보했지만, 주가는 하루 -4.16%였고 RSI14는 21.61까지 내려갔다. 3개 주 파일럿이라는 비가격 호재가 있었는데도 시장이 이를 거의 무시한 이유는, 현금 $2.0B보다 더 큰 자금소진·희석 리스크를 본 것인가?
Yes, that is the cleanest read from today’s files. The market looks like it is treating Archer’s eIPP win as strategically real but financially insufficient.
Start with the positive. Archer’s March 9 IR item says Florida, New York, and Texas were selected under the White House pilot framework. The summaries frame this as a serious operational step because those states can support route testing, vertiport integration, local approvals, and real-world operating lessons for the Midnight aircraft. In a vacuum, that should help the stock. It is exactly the kind of policy-backed validation growth investors usually want.
But the daily numbers show the market did not buy the headline on its own. Archer closed at $5.76, down 4.16% on the day, with volume at 34,097,381. Technicals were even harsher: SMA5 at 6.04 versus SMA20 at 6.56, plus RSI14 at 21.61. That is not just weak. That is deep oversold territory, and it tells you investors were actively leaning away from the name.
Why would that happen on a day when the company has a visible policy catalyst? Because the catalyst does not solve the balance-sheet debate. Archer’s article-summary file says the company had about $2.0 billion in cash or cash-like assets, and the same news coverage explicitly says investors remained worried about commercialization cost, timing uncertainty, and further financing risk. There are also repeated references in the summary set to operating losses, adjusted EBITDA loss, annual cash burn, and even dilution risk in third-party coverage.
That matters because eIPP is not revenue scale. It is an operating test framework. It can improve regulatory coordination and de-risk route learning, but it does not suddenly make the business less capital intensive. In fact, pilot programs can increase near-term spending because the company has to support aircraft deployment, operating personnel, charging or vertiport readiness, and coordination across multiple geographies before any meaningful revenue base exists.
The market seems to be asking a very blunt question: what if this is another milestone that consumes cash faster than it generates commercial proof?
That concern gets stronger because Archer is trying to hold together several narratives at once. The company says its U.S. and UAE pilot programs are on track for 2026. It announced Starlink onboard Midnight. It won visibility through the White House program. But the surrounding news flow also includes executive-role changes and articles focused on production shortfalls or dilution risk. So investors are not looking at the eIPP story in isolation. They are filtering it through the broader picture of execution strain.
The stock action suggests the market is saying this: a three-state pilot opportunity is good, but it is not enough to offset fear that the company will keep spending heavily before commercial economics are proven. In other words, the market may believe the $2.0 billion cash figure is real, yet still believe the runway can shrink faster than bulls expect if certification, production, and pilot operations all demand capital at once.
That is why the RSI matters. An RSI14 of 21.61 usually reflects extreme pessimism, but it does not tell you the stock is mispriced by definition. It can also tell you that investors are discounting a future financing overhang before it is formally announced. If the market believed the existing cash balance fully covered the 2026–2027 plan with comfortable margin, a White House-backed operational milestone probably would not have been greeted with a 4.16% drop.
My directional view is that investors are placing a larger weight on burn and dilution than on eIPP optionality. That looks bearish in the short term, though it also means Archer could rebound sharply if management proves that pilot deployments are being funded efficiently and without a looming capital raise. For now, policy support is not enough. The market wants evidence that the company can turn operational testing into a durable commercial bridge without reopening the financing question.
Q3: EHang은 직접 호재가 없는 날에도 주가가 -8.46%로 JOBY(-4.75%)와 ACHR(-4.16%)보다 더 크게 빠졌고, RSI14도 28.5로 과매도 구간이다. 그런데 ARKX 보유 상위에는 JOBY 2.74%, ACHR 4.10%만 보이고 EH는 없다. 섹터 약세 국면에서 ‘ETF 비보유’가 EH의 하방 탄력을 더 키우는 구조적 약점인가?
Yes, I think that is a real structural weakness, and today’s relative price move fits that argument very well.
The raw comparison is simple. EHang closed at $9.95 and fell 8.46%. Joby fell 4.75%. Archer fell 4.16%. EHang’s RSI14 was 28.5, which puts it in oversold territory alongside a broader death-cross setup in the sector. On pure price action, EHang took the hardest hit.
The input files do not show any fresh EHang IR catalyst driving that drop. In fact, the EHang daily report explicitly says there were no Tier-1 official EHang press releases or SEC filings within the reporting window. So if EHang fell harder without a company-specific headline, the market structure explanation becomes more compelling.
That is where the ETF point matters. The institutional snapshot in today’s files shows ARKX holding Archer at 4.10% and Joby at 2.74%. EHang does not appear as a material top holding. That does not automatically explain every down day, but it does tell you something about who is naturally positioned to provide thematic sponsorship when the sector gets hit.
ETF ownership matters because it creates a baseline source of visibility, liquidity, and passive demand. When a company sits inside a thematic basket, it can benefit from investors expressing a sector view through the ETF rather than through single-name conviction. That does not prevent declines, but it can cushion them by keeping the stock tied into broader flows. Joby and Archer appear to have that advantage, at least to some degree. EHang does not, based on the files in front of us.
In a weak tape, the absence of that support can make the downside feel more violent. If there is no meaningful ETF constituency and no fresh company-specific catalyst to anchor sentiment, the stock can trade more like an orphaned risk asset. That means thinner sponsorship, less automatic buying on sector enthusiasm, and more severe repricing when risk appetite disappears.
The contrast with Joby is especially useful. Joby was also down hard, and its technical setup is weak too. But Joby still has a visible place in ARKX at 2.74% and a recent stream of certification and operational headlines. Archer has an even bigger ARKX weight at 4.10% plus White House pilot-program visibility. EHang had neither of those cushions today. No new direct catalyst, no visible ARKX backing, and a sector-wide selloff. That combination is exactly what can produce the kind of underperformance we saw.
So I would answer the question directly: yes, ETF non-ownership looks like a structural discount factor for EH. Not because ETFs guarantee upside, but because exclusion can amplify downside when sentiment turns negative. It reduces the pool of natural buyers and leaves the stock more exposed to opportunistic selling.
My directional take is bearish on relative resilience. EHang can still rally sharply on its own catalysts, but in a broad eVTOL risk-off phase it looks more vulnerable than JOBY and ACHR because it lacks the same institutional basket support. Until that changes, EH may keep showing bigger percentage drawdowns even on days when nothing new happens at the company level.
What to Watch Tomorrow
First, watch whether Joby gives any additional detail on fleet count or aircraft allocation. The company’s 2026 story is getting stronger on narrative and weaker on disclosed hardware depth.
Second, watch whether Archer can shift investor focus from policy wins to capital discipline. The market already knows the three-state eIPP story. Now it wants proof that $2.0 billion is enough.
Third, watch whether EHang gets any institutional or catalyst support that offsets its structural isolation. Without that, sector weakness can keep hitting EH harder than peers.